[Relationship between clozapine plasma levels and withdrawal symptoms]

Autor: Berecz R, de la Rubia Martínez A, Mj, Norberto Gamero, Jr, Gutiérrez Casares, Glaub T, Degrell I, Adrián LLerena

Publikováno v: Europe PubMed Central

Discontinuation of clozapine and an attempt to change his medication to sertindol has led to serious psychotic and somatic symptoms in an schizophrenic patient treated with clozapine for five years, however after readministration of clozapine these s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::aecb7089476b024a13a37d4eacd93be9
https://pubmed.ncbi.nlm.nih.gov/12487951

In silico clinical trial evaluating lisdexamfetamine's and methylphenidate's mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients' population.

Autor: Gutiérrez-Casares JR; Unidad Ambulatoria de Psiquiatría y Salud Mental de la Infancia, Niñez y Adolescencia, Hospital Perpetuo Socorro, Badajoz, Spain., Quintero J; Servicio de Psiquiatría, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain., Segú-Vergés C; Anaxomics Biotech, Barcelona, Spain.; Structural Bioinformatics Group, Research Programme on Biomedical Informatics, Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain., Rodríguez Monterde P; Medical Department, Takeda Farmacéutica España, Madrid, Spain., Pozo-Rubio T; Medical Department, Takeda Farmacéutica España, Madrid, Spain., Coma M; Anaxomics Biotech, Barcelona, Spain., Montoto C; Medical Department, Takeda Farmacéutica España, Madrid, Spain.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2023 Jun 02; Vol. 14, pp. 939650. Date of Electronic Publication: 2023 Jun 02 (Print Publication: 2023).

Methods to Develop an in silico Clinical Trial: Computational Head-to-Head Comparison of Lisdexamfetamine and Methylphenidate.

Autor: Gutiérrez-Casares JR; Unidad Ambulatoria de Psiquiatría y Salud Mental de la Infancia, Niñez y Adolescencia, Hospital Perpetuo Socorro, Badajoz, Spain., Quintero J; Servicio de Psiquiatría, Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain., Jorba G; Anaxomics Biotech, Barcelona, Spain.; Research Programme on Biomedical Informatics (GRIB), Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain., Junet V; Anaxomics Biotech, Barcelona, Spain.; Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain., Martínez V; Medical Department, Takeda Farmacéutica España, Madrid, Spain., Pozo-Rubio T; Medical Department, Takeda Farmacéutica España, Madrid, Spain., Oliva B; Research Programme on Biomedical Informatics (GRIB), Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain., Daura X; Institute of Biotechnology and Biomedicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain., Mas JM; Anaxomics Biotech, Barcelona, Spain., Montoto C; Medical Department, Takeda Farmacéutica España, Madrid, Spain.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2021 Nov 03; Vol. 12, pp. 741170. Date of Electronic Publication: 2021 Nov 03 (Print Publication: 2021).

[Reversible brain perfusion changes in an acute depersonalization syndrome. Role of SPECT with (99m)Tc-ECD].

Autor: Serrano Vicente J; Servicio de Medicina Nuclear, Servicio de Psiquiatría, Complejo Hospitalario Universitario de Badajoz, Badajoz, España. titoserrano@gmail.com, García Bernardo L, Durán Barquero C, Rayo Madrid JI, Infante Torre JR, Domínguez Grande ML, Gutiérrez Casares JR

Publikováno v: Revista espanola de medicina nuclear [Rev Esp Med Nucl] 2011 Jan-Feb; Vol. 30 (1), pp. 39-40. Date of Electronic Publication: 2011 Jan 05.

Ziprasidone overdose: cardiac safety.

Autor: Insa Gómez FJ; Complejo Hospitalario Universitario, Badajoz, Spain. fjinsa@cavabianca.org, Gutiérrez Casares JR

Publikováno v: Actas espanolas de psiquiatria [Actas Esp Psiquiatr] 2005 Nov-Dec; Vol. 33 (6), pp. 398-400.